nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.109	0.152	CbGbCtD
Midodrine—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0968	0.135	CbGbCtD
Midodrine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0866	0.121	CbGbCtD
Midodrine—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0863	0.121	CbGbCtD
Midodrine—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0823	0.115	CbGbCtD
Midodrine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0631	0.0882	CbGbCtD
Midodrine—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0556	0.0778	CbGbCtD
Midodrine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0498	0.0696	CbGbCtD
Midodrine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0251	0.0351	CbGbCtD
Midodrine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0232	0.0324	CbGbCtD
Midodrine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.019	0.0266	CbGbCtD
Midodrine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0183	0.0255	CbGbCtD
Midodrine—Agomelatine—MTNR1A—type 2 diabetes mellitus	0.00298	0.345	CrCbGaD
Midodrine—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00175	0.202	CrCbGaD
Midodrine—Agomelatine—MTNR1B—type 2 diabetes mellitus	0.00157	0.181	CrCbGaD
Midodrine—Melatonin—MTNR1B—type 2 diabetes mellitus	0.000917	0.106	CrCbGaD
Midodrine—Melatonin—CALM1—type 2 diabetes mellitus	0.000562	0.065	CrCbGaD
Midodrine—Agomelatine—HTR2C—type 2 diabetes mellitus	0.0004	0.0462	CrCbGaD
Midodrine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00157	CcSEcCtD
Midodrine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000304	0.00156	CcSEcCtD
Midodrine—Flushing—Metformin—type 2 diabetes mellitus	0.000304	0.00156	CcSEcCtD
Midodrine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000304	0.00156	CcSEcCtD
Midodrine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000304	0.00156	CcSEcCtD
Midodrine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000303	0.00156	CcSEcCtD
Midodrine—Back pain—Valsartan—type 2 diabetes mellitus	0.000303	0.00156	CcSEcCtD
Midodrine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000302	0.00155	CcSEcCtD
Midodrine—Agomelatine—CYP1A2—type 2 diabetes mellitus	0.000302	0.0349	CrCbGaD
Midodrine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000301	0.00155	CcSEcCtD
Midodrine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000301	0.00155	CcSEcCtD
Midodrine—Back pain—Orlistat—type 2 diabetes mellitus	0.000299	0.00154	CcSEcCtD
Midodrine—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000299	0.00154	CcSEcCtD
Midodrine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000298	0.00153	CcSEcCtD
Midodrine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000297	0.00153	CcSEcCtD
Midodrine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000297	0.00153	CcSEcCtD
Midodrine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000297	0.00153	CcSEcCtD
Midodrine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00152	CcSEcCtD
Midodrine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000294	0.00151	CcSEcCtD
Midodrine—Chills—Metformin—type 2 diabetes mellitus	0.000294	0.00151	CcSEcCtD
Midodrine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000293	0.0015	CcSEcCtD
Midodrine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00029	0.00149	CcSEcCtD
Midodrine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00029	0.00149	CcSEcCtD
Midodrine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000289	0.00149	CcSEcCtD
Midodrine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000289	0.00149	CcSEcCtD
Midodrine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000289	0.00149	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000288	0.00148	CcSEcCtD
Midodrine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000288	0.00148	CcSEcCtD
Midodrine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000287	0.00148	CcSEcCtD
Midodrine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000287	0.00148	CcSEcCtD
Midodrine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000285	0.00146	CcSEcCtD
Midodrine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000284	0.00146	CcSEcCtD
Midodrine—Flatulence—Metformin—type 2 diabetes mellitus	0.000281	0.00145	CcSEcCtD
Midodrine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00028	0.00144	CcSEcCtD
Midodrine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00028	0.00144	CcSEcCtD
Midodrine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000279	0.00144	CcSEcCtD
Midodrine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000278	0.00143	CcSEcCtD
Midodrine—Chills—Irbesartan—type 2 diabetes mellitus	0.000277	0.00143	CcSEcCtD
Midodrine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000277	0.00143	CcSEcCtD
Midodrine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000277	0.00142	CcSEcCtD
Midodrine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000276	0.00142	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000275	0.00142	CcSEcCtD
Midodrine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000275	0.00141	CcSEcCtD
Midodrine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000274	0.00141	CcSEcCtD
Midodrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000273	0.0014	CcSEcCtD
Midodrine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000273	0.0014	CcSEcCtD
Midodrine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000273	0.0014	CcSEcCtD
Midodrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000271	0.0014	CcSEcCtD
Midodrine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000271	0.00139	CcSEcCtD
Midodrine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00027	0.00139	CcSEcCtD
Midodrine—Flushing—Losartan—type 2 diabetes mellitus	0.00027	0.00139	CcSEcCtD
Midodrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000269	0.00139	CcSEcCtD
Midodrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000269	0.00138	CcSEcCtD
Midodrine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00138	CcSEcCtD
Midodrine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000267	0.00138	CcSEcCtD
Midodrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000266	0.00137	CcSEcCtD
Midodrine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000266	0.00137	CcSEcCtD
Midodrine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000266	0.00137	CcSEcCtD
Midodrine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000265	0.00136	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000265	0.00136	CcSEcCtD
Midodrine—Tension—Irbesartan—type 2 diabetes mellitus	0.000264	0.00136	CcSEcCtD
Midodrine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000264	0.00136	CcSEcCtD
Midodrine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000263	0.00135	CcSEcCtD
Midodrine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000263	0.00135	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000262	0.00135	CcSEcCtD
Midodrine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000261	0.00134	CcSEcCtD
Midodrine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000261	0.00134	CcSEcCtD
Midodrine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000259	0.00133	CcSEcCtD
Midodrine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000258	0.00133	CcSEcCtD
Midodrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000255	0.00131	CcSEcCtD
Midodrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000255	0.00131	CcSEcCtD
Midodrine—Rash—Glipizide—type 2 diabetes mellitus	0.000254	0.00131	CcSEcCtD
Midodrine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000254	0.0013	CcSEcCtD
Midodrine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000253	0.0013	CcSEcCtD
Midodrine—Headache—Glipizide—type 2 diabetes mellitus	0.000252	0.0013	CcSEcCtD
Midodrine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000252	0.00129	CcSEcCtD
Midodrine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000251	0.00129	CcSEcCtD
Midodrine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00025	0.00128	CcSEcCtD
Midodrine—Flatulence—Losartan—type 2 diabetes mellitus	0.00025	0.00128	CcSEcCtD
Midodrine—Tension—Losartan—type 2 diabetes mellitus	0.000249	0.00128	CcSEcCtD
Midodrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000248	0.00128	CcSEcCtD
Midodrine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000248	0.00128	CcSEcCtD
Midodrine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000248	0.00128	CcSEcCtD
Midodrine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000248	0.00127	CcSEcCtD
Midodrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00127	CcSEcCtD
Midodrine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000247	0.00127	CcSEcCtD
Midodrine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000247	0.00127	CcSEcCtD
Midodrine—Hypertension—Metformin—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Midodrine—Nervousness—Losartan—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Midodrine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000245	0.00126	CcSEcCtD
Midodrine—Back pain—Losartan—type 2 diabetes mellitus	0.000245	0.00126	CcSEcCtD
Midodrine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000245	0.00126	CcSEcCtD
Midodrine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000245	0.00126	CcSEcCtD
Midodrine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000243	0.00125	CcSEcCtD
Midodrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000243	0.00125	CcSEcCtD
Midodrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000242	0.00124	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000241	0.00124	CcSEcCtD
Midodrine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00024	0.00124	CcSEcCtD
Midodrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000239	0.00123	CcSEcCtD
Midodrine—Pain—Gliclazide—type 2 diabetes mellitus	0.000238	0.00122	CcSEcCtD
Midodrine—Rash—Glimepiride—type 2 diabetes mellitus	0.000237	0.00122	CcSEcCtD
Midodrine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000237	0.00122	CcSEcCtD
Midodrine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00121	CcSEcCtD
Midodrine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00121	CcSEcCtD
Midodrine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000236	0.00121	CcSEcCtD
Midodrine—Headache—Glimepiride—type 2 diabetes mellitus	0.000235	0.00121	CcSEcCtD
Midodrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000235	0.00121	CcSEcCtD
Midodrine—Agitation—Losartan—type 2 diabetes mellitus	0.000233	0.0012	CcSEcCtD
Midodrine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000232	0.0012	CcSEcCtD
Midodrine—Flushing—Ramipril—type 2 diabetes mellitus	0.000232	0.00119	CcSEcCtD
Midodrine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000231	0.00119	CcSEcCtD
Midodrine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000229	0.00118	CcSEcCtD
Midodrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000229	0.00118	CcSEcCtD
Midodrine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Midodrine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Midodrine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Midodrine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Midodrine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000227	0.00117	CcSEcCtD
Midodrine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000227	0.00117	CcSEcCtD
Midodrine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000227	0.00117	CcSEcCtD
Midodrine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000226	0.00116	CcSEcCtD
Midodrine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000225	0.00116	CcSEcCtD
Midodrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00115	CcSEcCtD
Midodrine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000224	0.00115	CcSEcCtD
Midodrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000223	0.00115	CcSEcCtD
Midodrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00114	CcSEcCtD
Midodrine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000222	0.00114	CcSEcCtD
Midodrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000222	0.00114	CcSEcCtD
Midodrine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000221	0.00113	CcSEcCtD
Midodrine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00022	0.00113	CcSEcCtD
Midodrine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000219	0.00113	CcSEcCtD
Midodrine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000219	0.00112	CcSEcCtD
Midodrine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000218	0.00112	CcSEcCtD
Midodrine—Pain—Orlistat—type 2 diabetes mellitus	0.000216	0.00111	CcSEcCtD
Midodrine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000215	0.00111	CcSEcCtD
Midodrine—Anxiety—Losartan—type 2 diabetes mellitus	0.000215	0.00111	CcSEcCtD
Midodrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Midodrine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Midodrine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Midodrine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Midodrine—Tension—Ramipril—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Midodrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00109	CcSEcCtD
Midodrine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000211	0.00108	CcSEcCtD
Midodrine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000211	0.00108	CcSEcCtD
Midodrine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000209	0.00108	CcSEcCtD
Midodrine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000209	0.00108	CcSEcCtD
Midodrine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000209	0.00107	CcSEcCtD
Midodrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000208	0.00107	CcSEcCtD
Midodrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000208	0.00107	CcSEcCtD
Midodrine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Midodrine—Somnolence—Metformin—type 2 diabetes mellitus	0.000207	0.00106	CcSEcCtD
Midodrine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000206	0.00106	CcSEcCtD
Midodrine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000205	0.00105	CcSEcCtD
Midodrine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000203	0.00104	CcSEcCtD
Midodrine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000202	0.00104	CcSEcCtD
Midodrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000202	0.00104	CcSEcCtD
Midodrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Midodrine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000201	0.00103	CcSEcCtD
Midodrine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.0002	0.00103	CcSEcCtD
Midodrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.0002	0.00103	CcSEcCtD
Midodrine—Agitation—Ramipril—type 2 diabetes mellitus	0.0002	0.00103	CcSEcCtD
Midodrine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000197	0.00101	CcSEcCtD
Midodrine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000197	0.00101	CcSEcCtD
Midodrine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Midodrine—Rash—Glyburide—type 2 diabetes mellitus	0.000195	0.001	CcSEcCtD
Midodrine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000195	0.001	CcSEcCtD
Midodrine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000195	0.001	CcSEcCtD
Midodrine—Headache—Glyburide—type 2 diabetes mellitus	0.000194	0.000998	CcSEcCtD
Midodrine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000193	0.000995	CcSEcCtD
Midodrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000192	0.000987	CcSEcCtD
Midodrine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00019	0.000979	CcSEcCtD
Midodrine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00019	0.000975	CcSEcCtD
Midodrine—Pain—Irbesartan—type 2 diabetes mellitus	0.000188	0.000966	CcSEcCtD
Midodrine—Insomnia—Losartan—type 2 diabetes mellitus	0.000187	0.000962	CcSEcCtD
Midodrine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000186	0.000955	CcSEcCtD
Midodrine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Midodrine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Midodrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000184	0.000947	CcSEcCtD
Midodrine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000184	0.000946	CcSEcCtD
Midodrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000184	0.000946	CcSEcCtD
Midodrine—Somnolence—Losartan—type 2 diabetes mellitus	0.000184	0.000945	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000184	0.000944	CcSEcCtD
Midodrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000183	0.000943	CcSEcCtD
Midodrine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000182	0.000936	CcSEcCtD
Midodrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000181	0.000932	CcSEcCtD
Midodrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000181	0.000931	CcSEcCtD
Midodrine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000181	0.00093	CcSEcCtD
Midodrine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000181	0.00093	CcSEcCtD
Midodrine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00018	0.000924	CcSEcCtD
Midodrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000179	0.000919	CcSEcCtD
Midodrine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000179	0.000919	CcSEcCtD
Midodrine—Pain—Losartan—type 2 diabetes mellitus	0.000177	0.000909	CcSEcCtD
Midodrine—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000177	0.0204	CrCbGaD
Midodrine—Rash—Gliclazide—type 2 diabetes mellitus	0.000175	0.000902	CcSEcCtD
Midodrine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000175	0.000901	CcSEcCtD
Midodrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000174	0.000896	CcSEcCtD
Midodrine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.000894	CcSEcCtD
Midodrine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000174	0.000893	CcSEcCtD
Midodrine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000173	0.00089	CcSEcCtD
Midodrine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.000886	CcSEcCtD
Midodrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00017	0.000876	CcSEcCtD
Midodrine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000169	0.000869	CcSEcCtD
Midodrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000169	0.000869	CcSEcCtD
Midodrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000167	0.000859	CcSEcCtD
Midodrine—Asthenia—Metformin—type 2 diabetes mellitus	0.000167	0.000859	CcSEcCtD
Midodrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000165	0.00085	CcSEcCtD
Midodrine—Pruritus—Metformin—type 2 diabetes mellitus	0.000165	0.000847	CcSEcCtD
Midodrine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000163	0.000841	CcSEcCtD
Midodrine—Rash—Valsartan—type 2 diabetes mellitus	0.000161	0.000829	CcSEcCtD
Midodrine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000161	0.000828	CcSEcCtD
Midodrine—Insomnia—Ramipril—type 2 diabetes mellitus	0.00016	0.000825	CcSEcCtD
Midodrine—Headache—Valsartan—type 2 diabetes mellitus	0.00016	0.000824	CcSEcCtD
Midodrine—Rash—Orlistat—type 2 diabetes mellitus	0.000159	0.000819	CcSEcCtD
Midodrine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000159	0.000819	CcSEcCtD
Midodrine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000159	0.000818	CcSEcCtD
Midodrine—Headache—Orlistat—type 2 diabetes mellitus	0.000158	0.000814	CcSEcCtD
Midodrine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000158	0.000813	CcSEcCtD
Midodrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000158	0.000811	CcSEcCtD
Midodrine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000158	0.00081	CcSEcCtD
Midodrine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000156	0.000803	CcSEcCtD
Midodrine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000155	0.000799	CcSEcCtD
Midodrine—Dizziness—Metformin—type 2 diabetes mellitus	0.000154	0.000792	CcSEcCtD
Midodrine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000153	0.000787	CcSEcCtD
Midodrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000152	0.000781	CcSEcCtD
Midodrine—Nausea—Orlistat—type 2 diabetes mellitus	0.00015	0.000772	CcSEcCtD
Midodrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000148	0.000763	CcSEcCtD
Midodrine—Rash—Metformin—type 2 diabetes mellitus	0.000147	0.000755	CcSEcCtD
Midodrine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000147	0.000754	CcSEcCtD
Midodrine—Pruritus—Losartan—type 2 diabetes mellitus	0.000146	0.000752	CcSEcCtD
Midodrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000146	0.000751	CcSEcCtD
Midodrine—Headache—Metformin—type 2 diabetes mellitus	0.000146	0.00075	CcSEcCtD
Midodrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000145	0.000747	CcSEcCtD
Midodrine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000145	0.000746	CcSEcCtD
Midodrine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00014	0.000721	CcSEcCtD
Midodrine—Rash—Irbesartan—type 2 diabetes mellitus	0.000138	0.000712	CcSEcCtD
Midodrine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000138	0.000712	CcSEcCtD
Midodrine—Nausea—Metformin—type 2 diabetes mellitus	0.000138	0.000711	CcSEcCtD
Midodrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000138	0.000708	CcSEcCtD
Midodrine—Dizziness—Losartan—type 2 diabetes mellitus	0.000137	0.000703	CcSEcCtD
Midodrine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00013	0.000671	CcSEcCtD
Midodrine—Rash—Losartan—type 2 diabetes mellitus	0.00013	0.00067	CcSEcCtD
Midodrine—Dermatitis—Losartan—type 2 diabetes mellitus	0.00013	0.00067	CcSEcCtD
Midodrine—Headache—Losartan—type 2 diabetes mellitus	0.000129	0.000666	CcSEcCtD
Midodrine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000127	0.000654	CcSEcCtD
Midodrine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000125	0.000645	CcSEcCtD
Midodrine—Nausea—Losartan—type 2 diabetes mellitus	0.000123	0.000632	CcSEcCtD
Midodrine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000117	0.000603	CcSEcCtD
Midodrine—Rash—Ramipril—type 2 diabetes mellitus	0.000112	0.000575	CcSEcCtD
Midodrine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000112	0.000574	CcSEcCtD
Midodrine—Headache—Ramipril—type 2 diabetes mellitus	0.000111	0.000571	CcSEcCtD
Midodrine—Nausea—Ramipril—type 2 diabetes mellitus	0.000105	0.000542	CcSEcCtD
Midodrine—ADRA1B—Signaling by GPCR—C3—type 2 diabetes mellitus	1.6e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.59e-05	0.000194	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.59e-05	0.000194	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.59e-05	0.000193	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.57e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.55e-05	0.000189	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.55e-05	0.000189	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.55e-05	0.000188	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.55e-05	0.000188	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.54e-05	0.000188	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.53e-05	0.000187	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.52e-05	0.000186	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.52e-05	0.000186	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.51e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.51e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.51e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.5e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.5e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.49e-05	0.000182	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.49e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.49e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.49e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.48e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.48e-05	0.00018	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.47e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.47e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.47e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.46e-05	0.000178	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.45e-05	0.000177	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.45e-05	0.000176	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.43e-05	0.000174	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.42e-05	0.000172	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.41e-05	0.000172	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.41e-05	0.000171	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.4e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.4e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.4e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.4e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.39e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.38e-05	0.000168	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.37e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AVP—type 2 diabetes mellitus	1.37e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.37e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.37e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.37e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.36e-05	0.000166	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.36e-05	0.000166	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.36e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.35e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.000164	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GCG—type 2 diabetes mellitus	1.34e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.34e-05	0.000163	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.34e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.34e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.33e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.33e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOB—type 2 diabetes mellitus	1.33e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.32e-05	0.000161	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.32e-05	0.000161	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.32e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.31e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.31e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.3e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.3e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.29e-05	0.000157	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LPL—type 2 diabetes mellitus	1.27e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.26e-05	0.000153	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.25e-05	0.000152	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.24e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.24e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.23e-05	0.00015	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.00015	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.21e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.21e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.19e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.19e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.19e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.17e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.17e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.17e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.17e-05	0.000142	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.16e-05	0.000142	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.16e-05	0.000141	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—C3—type 2 diabetes mellitus	1.14e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.14e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.14e-05	0.000139	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.14e-05	0.000139	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.14e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.14e-05	0.000138	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.13e-05	0.000138	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.12e-05	0.000136	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.12e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.12e-05	0.000136	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.11e-05	0.000135	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.11e-05	0.000135	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.11e-05	0.000135	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.1e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.1e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.1e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.1e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.09e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.09e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—type 2 diabetes mellitus	1.09e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.08e-05	0.000132	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.08e-05	0.000132	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.07e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.07e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—type 2 diabetes mellitus	1.06e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—type 2 diabetes mellitus	1.06e-05	0.00013	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.05e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.05e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.04e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.03e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.03e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.01e-05	0.000123	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.01e-05	0.000123	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.01e-05	0.000123	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1e-05	0.000122	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1e-05	0.000122	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.95e-06	0.000121	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.95e-06	0.000121	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.95e-06	0.000121	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.94e-06	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.88e-06	0.00012	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.79e-06	0.000119	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.77e-06	0.000119	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.75e-06	0.000119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.7e-06	0.000118	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.68e-06	0.000118	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.64e-06	0.000117	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.48e-06	0.000116	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	9.48e-06	0.000115	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.47e-06	0.000115	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.35e-06	0.000114	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.15e-06	0.000112	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	9.1e-06	0.000111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—type 2 diabetes mellitus	9.08e-06	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.04e-06	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.02e-06	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	9.01e-06	0.00011	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	9e-06	0.00011	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	9e-06	0.00011	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.94e-06	0.000109	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.85e-06	0.000108	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	8.82e-06	0.000108	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	8.82e-06	0.000108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.78e-06	0.000107	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.78e-06	0.000107	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.78e-06	0.000107	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.77e-06	0.000107	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.74e-06	0.000106	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.72e-06	0.000106	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.63e-06	0.000105	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.63e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.61e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.42e-06	0.000103	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.34e-06	0.000102	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.32e-06	0.000101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.03e-06	9.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.01e-06	9.76e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	8e-06	9.75e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.96e-06	9.7e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.96e-06	9.7e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.87e-06	9.59e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.87e-06	9.58e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.84e-06	9.55e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.84e-06	9.55e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.75e-06	9.44e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	7.54e-06	9.18e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	7.5e-06	9.13e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.44e-06	9.06e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.44e-06	9.06e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.42e-06	9.04e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.4e-06	9.02e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.39e-06	9e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.3e-06	8.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.29e-06	8.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.29e-06	8.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.26e-06	8.84e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	7.09e-06	8.64e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.99e-06	8.52e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.92e-06	8.44e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.9e-06	8.4e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.82e-06	8.31e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.77e-06	8.25e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.76e-06	8.24e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.72e-06	8.18e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.7e-06	8.16e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.63e-06	8.07e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.61e-06	8.05e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.61e-06	8.05e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.61e-06	8.05e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.59e-06	8.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.48e-06	7.89e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.47e-06	7.88e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.44e-06	7.85e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.43e-06	7.84e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.39e-06	7.79e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.35e-06	7.74e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.32e-06	7.7e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	6.22e-06	7.58e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.2e-06	7.55e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.15e-06	7.49e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	6.1e-06	7.43e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.98e-06	7.29e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	5.89e-06	7.18e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.87e-06	7.15e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.87e-06	7.15e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.79e-06	7.06e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.74e-06	6.99e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.7e-06	6.94e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.67e-06	6.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.66e-06	6.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.61e-06	6.84e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.61e-06	6.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.58e-06	6.79e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.53e-06	6.73e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.3e-06	6.46e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.27e-06	6.42e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.25e-06	6.39e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.16e-06	6.29e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.14e-06	6.27e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.03e-06	6.13e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.99e-06	6.07e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.95e-06	6.03e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.94e-06	6.02e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.89e-06	5.96e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.85e-06	5.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.76e-06	5.8e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.71e-06	5.74e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.66e-06	5.68e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.57e-06	5.57e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.44e-06	5.42e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.37e-06	5.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.34e-06	5.29e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.29e-06	5.22e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.25e-06	5.18e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.25e-06	5.18e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.23e-06	5.15e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	3.97e-06	4.83e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.89e-06	4.74e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.88e-06	4.73e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.81e-06	4.64e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.66e-06	4.46e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.29e-06	4.01e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.04e-06	3.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.93e-06	3.56e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.7e-06	3.29e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.95e-06	2.38e-05	CbGpPWpGaD
